Rectal neuroendocrine neoplasms (r-NENs) are considered among the most frequent
digestive NENs, together with small bowel NENs. Their incidence has increased over the …

Rectal neuroendocrine tumors (NETs) are rare, with an incidence of 0.17%, but they
represent 12% to 27% of all NETs and 20% of gastrointestinal NETs. Although rectal NETs …

Introduction Well-differentiated gastric, duodenal, and rectal neuroendocrine neoplasms
(NETs) are rare diseases usually managed by endoscopic treatment. Although several …

The estimated annual incidence of R-NENs is 1.04 per 100,000 persons although the real
incidence may be underestimated, as not all R-NEN are systematically reported in registers …

Rectal neuroendocrine tumors (RNET) are rare tumors but their prevalence is constantly
increasing due to a prolonged survival and rising incidence related to a growing number of …

Background The incidence of rectal neuroendocrine tumors (NETs) is rapidly increasing
because of the frequent use of endoscopic screening for colorectal cancers. However, the …

The present paper reflects the position of the Italian Association for Neuroendocrine Tumors
(Itanet), the Italian Society of Gastroenterology (SIGE), and the Italian Society of Digestive …

Background Endoscopic submucosal dissection (ESD) has been widely adopted in treating
rectal neuroendocrine tumors (NETs). However, clinical outcomes in rectal NETs after ESD …

Opinion statement Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs)
comprise a heterogeneous group of slow growing tumors arising from the neuroendocrine …

Background and Aims Prevalence of rectal carcinoids is increasing, partly because of
increased colorectal cancer screening. Local excision (endoscopic or transanal excision) is …